Enter your Email Address


Useful Links

Know What The Insiders Are Doing!
Stock Trading Software

More Links




[Most Recent Quotes from www.kitco.com]

[Most Recent Quotes from www.kitco.com]




ThinkEquity’s Woodburn Rates Verenium (Nasdaq:VRNM) at BUY – $3 Price Target

Small Cap Pulse (May 14th, 2009) Writes:
May 13, 2009 ndash; Analyst Comments ndash; ThinkEquityrsquo;s David Woodburn commented on Verenium (Nasdaq:VRNM) this morning, rating the stock at BUY with a price target of $3 (the stock closed at $0.61 yesterday). He cited improving enzyme profitability. Verenium reported Q1 financial results on Monday. Financial Results Verenium reported Q1 revenues of $14.4 million, compared with $15.2 million for the same period last year and a net loss of $0.3 million, compared with a $23.1 million net loss last year. Woodburnrsquo;s Takeaways middot;nbsp;nbsp;nbsp;nbsp;nbsp;nbsp;nbsp;nbsp; Improved profitability in Specialty Enzyme business middot;nbsp;nbsp;nbsp;nbsp;nbsp;nbsp;nbsp;nbsp; British Petroleumrsquo;s upfront cash contributions serve as validation of Vereniumrsquo;s technology and commercial prospects middot;nbsp;nbsp;nbsp;nbsp;nbsp;nbsp;nbsp;nbsp; New government incentives should facilitates scale-up to commercial levels middot;nbsp;nbsp;nbsp;nbsp;nbsp;nbsp;nbsp;nbsp; Product gross margin of 45.5% middot;nbsp;nbsp;nbsp;nbsp;nbsp;nbsp;nbsp;nbsp; Reconfigured revenue and gross margin forecasts to account for Danisco agreement as well as boosts to production utilization and yield. FY09 revenue forecast declines to $65Mnbsp; from $90M but product GM is increased to ...

Geithner Is LYING… This Investigation into Banks Is Proof

Contrarian Profits (April 6th, 2009) Writes:
Notes from the Investment Underground San Telmo, Buenos Aires, Argentina

April 6, 2009

Why the economy is still heading for a cliff… All the king’s horses and all the king’s men can’t put the banks back together again… The madness of Sheila Bair… The government lies over banks are paper thin… Infighting at the Treasury… Why Citi’s CEO should go… Banks plunge… “Fake dividend” strategy exposed… Can mark-to-model save them? Selling OTM calls against your financial stocks… What happened on March 9… And more!

*** You’re reading this newsletter because you don’t believe the cheerleaders in Washington and in the mainstream press. You know it’s safer to know the truth about the economy than to believe the hype and the lies and the false optimism. You know that real money-making ideas can’t be found on CNN and

...
Tags for this Post:
Aig, Andrew Gordon, Andy Beal;, Argentina, Bank, Bank Stocks, Beal Bank;, bloomberg, Brian Hunt;, Buenos Aires, Calyon Securities;, CBS, cent;, Chris Hunter;, Citi, Citigroup, Cnn, Congress, contrarian profits, Crisis Strategy Alert;, Depression, Dow 30, Dublin, Face the Nation;, Fannie Mae, Fda, Fdic, Federal Government, Felix Salmon, Freddie Mac, Frederick, gm, Goldman Sachs, Ireland, Karim Rahemtulla, Larry Summers;, Mad Money, mark-to-market accounting rules, Market Commentary, Maryland, Mike Mayo;, Nasdaq 100, New government;, on-line publication, Patrick Cox;, Prostate Cancer, real estate hasn;, Reuters, Sheila Bair, Sp 500, Stansberry & Associates;, technology expert;, Tim Geithner;, Timothy Geithner;, Tom Dyson;, Treasury, United States, Us Government, USD, Washington, wells fargo, White House, Will Bonner;

Newsletter

No recommendations, either expressed or implied, are being made to buy, sell, hold or short any of the mentioned stocks. No legal, tax or accounting advice is expressed or implied. Always contact your attorney, CPA, or tax advisor before acting on any legal or tax issues. StraightStocks.com is not responsible for the content, products, or services of any of the advertisers on this site. StraightStocks.com receives compensation from advertisers on this blog. Services and products referred to herein are trademarks, registered trademarks, servicemarks, and/or registered servicemarks of their respective trademark or servicemark owners.